Risk factors for acute graft‐versus‐host disease

Summary. Acute graft‐versus‐host disease (GvHD) is an important complication of bone marrow transplantation in humans. Risk factors are imprecisely defined and controversial. We analysed data from 2036 recipients of HLA‐identical sibling transplants for leukaemia or aplastic anaemia to identify risk factors for GvHD. Analyses indicate that grading of GvHD can be reproducibly divided into absent or mild versus moderate to severe; 2‐year actuarial probability was 54% (95% confidence interval 52–56%) for absent or mild and 46% (44–48%) for moderate to severe. Factors predictive of development of moderate to severe GvHD include donor/recipient sex‐match (female→male greater than others, relative risk 2.0, P<0.001). This risk was markedly increased if female donors for male recipients were previously pregnant or transfused (relative risk 2.9, P<0.0001). Older patients were at increased risk of GvHD (relative risk 1.6, P<0.001), but the age gradient was modest, even the youngest patients had a substantial risk of GvHD and, if parous or transfused female→male transplants were excluded, age was not a significant risk factor. Cyclosporine or methotrexate were equally effective at preventing GvHD and were superior to no prophylaxis (relative risk 2.3, P<0.01). These data should be useful in estimating the risk of acute GvHD in an individual patient and in designing clinical trials to investigate methods to modify or prevent GvHD.

[1]  R. Hoppe,et al.  Engraftment of allogeneic bone marrow without graft-versus-host disease in mongrel dogs using total lymphoid irradiation. , 1980, Transplantation.

[2]  J. Biggs,et al.  Female marrow donors increase the risk of acute graft‐versus‐host disease: effect of donor age and parity and analysis of cell subpopulations in the donor marrow inoculum , 1986, British journal of haematology.

[3]  H. Braine,et al.  Bone marrow transplantation with major ABO blood group incompatibility using erythrocyte depletion of marrow prior to infusion. , 1982, Blood.

[4]  Z. Fuks,et al.  Transplantation of allogeneic bone marrow without graft-versus-host disease using total lymphoid irradiation , 1978, The Journal of experimental medicine.

[5]  H. Deeg,et al.  Marrow transplantation for severe aplastic anemia. Long-term outcome in fifty "untransfused" patients. , 1986, Annals of internal medicine.

[6]  W. Elkins Cellular Immunology and the Pathogenesis of Graft Versus Host Reactions (Part 1 of 3) , 1971 .

[7]  R. Brookmeyer,et al.  Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. , 1983, The New England journal of medicine.

[8]  V. Farewell,et al.  Protective environment for marrow transplant recipients: a prospective study. , 1978, Annals of internal medicine.

[9]  B. Nilsson,et al.  DEATH BY GRAFT‐VERSUS‐HOST DISEASE ASSOCIATED WITH HLA MISMATCH, HIGH RECIPIENT AGE, LOW MARROW CELL DOSE, AND SPLENECTOMY , 1985, Transplantation.

[10]  R. Gale,et al.  ABH Antigens and Bone Marrow Transplantation , 1980, British journal of haematology.

[11]  L. Robison,et al.  A randomized study of the prevention of acute graft-versus-host disease. , 1982, The New England journal of medicine.

[12]  J. Graham-Pole,et al.  Incidence of acute graft-versus-host disease with and without methotrexate prophylaxis in allogeneic bone marrow transplant patients. , 1984, Blood.

[13]  H. Braine,et al.  Bone marrow transplantation with major ABO blood group incompatibility using erythrocyte depletion of marrow prior to infusion , 1982 .

[14]  Graft-versus-host disease after marrow transplantation. , 1984, Lancet.

[15]  H. Deeg,et al.  Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. , 1986, The New England journal of medicine.

[16]  R. Gale,et al.  GRAFT REJECTION AND GRAFT-VERSUS-HOST DISEASE: MIRROR IMAGES , 1986, The Lancet.

[17]  R. Storb,et al.  Treatment of aplastic anemia by marrow transplantation from HLA identical siblings. Prognostic factors associated with graft versus host disease and survival. , 1977, The Journal of clinical investigation.

[18]  G. Hutchins,et al.  Lymphocytic bronchitis associated with graft-versus-host disease in recipients of bone-marrow transplants. , 1978, The New England journal of medicine.

[19]  H. Deeg,et al.  Marrow transplantation for aplastic anemia. , 1974, Seminars in hematology.

[20]  J. Fahey,et al.  Immune interventions in disease. , 1987, Annals of internal medicine.

[21]  A. Rimm,et al.  Bone marrow transplantation for acute myelogenous leukemia. Factors associated with early mortality. , 1983, JAMA.

[22]  E. Gluckman,et al.  Bone Marrow Transplantation in Severe Aplastic Anaemia: a Survey of the European Group for Bone Marrow Transplantation (E.G.B.M.T.) * , 1981, British journal of haematology.

[23]  R. Storb,et al.  Pulmonary function of marrow transplant patients. I. Effects of marrow infusion, acute graft-versus-host disease, and interstitial pneumonitis. , 1984, Experimental hematology.

[24]  R. Storb,et al.  Treatment of graft‐versus‐host disease in human allogeneic marrow graft recipients: A randomized trial comparing antithymocyte globulin and corticosteroids , 1981, American journal of hematology.

[25]  S. Feig,et al.  ABO blood group system and bone marrow transplantation , 1977 .

[26]  D. Uphoff Comparative survival of lethally irradiated inbred male mice inoculated with marrow from virgin or multiparous female donors. , 1975, Journal of the National Cancer Institute.

[27]  K. Sullivan,et al.  Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. , 1983, The New England journal of medicine.

[28]  A. Rimm,et al.  Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors. , 1986, Annals of internal medicine.

[29]  W. Elkins Cellular immunology and the pathogenesis of graft versus host reactions. , 1971, Progress in allergy.

[30]  Mortensen Tm Benzidine positive multicentric eosinophilic colonies in human blood mimicking erythroid bursts. , 1982 .

[31]  E. Mellits,et al.  Predictive factors for acute graft-versus-host disease in patients transplanted with HLA-identical bone marrow. , 1984, Blood.

[32]  R. Storb,et al.  Failure of early administration of antithymocyte globulin to lessen graft-versus-host disease in human allogeneic marrow transplant recipients. , 1981, Transplantation.

[33]  D. van der Waaij,et al.  Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora. , 1974, Journal of the National Cancer Institute.

[34]  A. Barrett,et al.  Cyclosporin A as prophylaxis against graft-versus-host disease in 36 patients. , 1982, British medical journal.

[35]  A. Rimm,et al.  Allogeneic bone marrow transplantation for 144 patients with severe aplastic anemia. , 1981, JAMA.

[36]  W. J. Martin,et al.  Cytomegalovirus infections associated with leukocyte transfusions. , 1980, Annals of internal medicine.

[37]  E. Thomas,et al.  Marrow transplantation for children with acute nonlymphoblastic leukemia in first remission. , 1981, Medical and pediatric oncology.

[38]  R. Nuscher,et al.  Bone marrow transplantation. , 1977, The American journal of nursing.

[39]  J. Dowling,et al.  Enhancement of murine cytomegalovirus infection during graft-vs.-host reaction. , 1977, The Journal of infectious diseases.

[40]  P. Weiden Graft-v-host disease following blood transfusions. , 1984, Archives of internal medicine.

[41]  H. Deeg,et al.  Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic marrow transplantation. , 1986, Blood.

[42]  A. Rimm,et al.  Severe combined immunodeficiency disease: characterization of the disease and results of transplantation. , 1977, Transplantation proceedings.

[43]  M. Bennett,et al.  Effect of irradiated mouse spleen cells on severity of graft-versus-host disease. , 1978, Transplantation.

[44]  A. Toivanen,et al.  Graft-versus-host reaction in 3 adult leukaemia patients after transfusion of blood cell products. , 2009, Scandinavian journal of haematology.

[45]  H. Deeg,et al.  Bone marrow transplantation in patients aged 45 years and older. , 1986, Blood.

[46]  D. Karnofsky,et al.  The use of the nitrogen mustards in the palliative treatment of carcinoma. With particular reference to bronchogenic carcinoma , 1948 .

[47]  J. Shanley,et al.  AUGMENTATION OF GRAFT‐VERSUS‐HOST REACTION BY CYTOMEGALOVIRUS INFECTION RESULTING IN INTERSTITIAL PNEUMONITIS , 1985, Transplantation.

[48]  M. Simonsen Graft‐versus‐Host‐Reactions: The History that never Was, and the Way Things Happened to Happen , 1985, Immunological reviews.

[49]  D. Higby,et al.  Graft-versus-host reaction following blood product transfusion. , 1982, The American journal of medicine.